Theconcept of innovative needles holds immense potential to transform thetreatment approaches for chronic diseases. The integration of various advancedtechnologies have facilitated the smooth transition of needles from research toclinical application.
The globalneedles market size is projected to grow from $8.1 billion in 2025 to $14.7billion by 2035, representing a CAGR of 6.1% during the forecast period.
Needles have emerged as a critical tool in healthcare asthey are being used for a variety of purposes, including drug delivery,vaccination and body fluid extraction. It is worth mentioning that their design and functionality have evolvedsignificantly since their inception in the 19th century, impacting bothclinical practices and patient experiences. During our research, we identifiedover 475 needle providers engaged in the global needles market.
The needles market is highly fragmented, featuring thepresence of both established companies as well as emerging start-ups. Most(200) of the needle manufacturers and developers were established between1991-2010. Notably, seven players have entered the domain post-2020; theseinclude (in reverse chronological order) White Plus Innovations (2023), FostechSolutions (2022), Calminject (2021), Corza Medical (2021), Neucell (2021),Nubeno Healthcare (2021) and Suyash Healthcare (2021).
Majority (250) of the companies provide needles thatadminister drugs via intravenous route. This is indicative of the fact thatthis intravenous mode of delivery enables faster absorption of medications intothe bloodstream, leading to a rapid onset of therapeutic action as compared toother modes of delivery. This isfollowed by the companies providing needles that are capable of administeringdrugs via hypodermic (221) and subcutaneous (162) route. It is worth mentioningthat subcutaneous route is less painful, owing to the integration of shorterand thinner needles. Notable examples ofcompanies providing needles to administer medications via subcutaneous routeinclude (based in France, in alphabetical order) Perouse, Pikdare, SUTUREX& RENODEX and Vygon.
The majority of the blood collection needles (121) aresafety needles. This can be attributed to the retractable nature of safetyneedles that prevents needlestick injuries. Further, it is observed that mostof the suture needles are conventional needles. This is an indicative of thefact that surgical procedures involve the usage of conventional needles becauseof their ability to penetrate through epidermal tissues like skin, which isessential to achieve precise suturing results. , Examples of the players using conventionalsuture needles include (based in Turkey, in alphabetical order) Aleda Makina,Setpa and SKY Biotechnology.
Research Methodology
Our analysts have performed an accurate examination of thevarious aspects of the global market leveraging avant-garde primary andsecondary sources of data collection. The report has gathered the necessarydata and information from several reliable sources. Additionally, the reportoffers many strategic recommendations for companies involved in thisever-growing business sector to help them attain a competitive edge in theNeedles Market.
Thank you for readingour report. Kindly get in touch with us to know more about the report or toreceive a customized copy of it. Our team will ensure the report is tailoredaccording to your needs.
Browse for more related reports:
